Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test.
Ether treatment was studied as a method of increasing the ability of type B influenza antigen to detect antibody by hemagglutination inhibition. Comparisons were made with the untreated antigen, with an eluate made from the same virus, and with a standard type B antigen of an earlier virus. Results...
保存先:
| 出版年: | J Clin Microbiol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1981
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC273720/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7462419/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.13.1.54-57.1981 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|